Long-term Review of a Cohort of Arthroscopic Bankart Interventions
NCT ID: NCT03654118
Last Updated: 2018-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
125 participants
OBSERVATIONAL
2017-08-07
2017-11-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Surgical treatment has been proposed for a long time by the reintegration of the labrum (intervention of Bankart) then by the making of an osteo-muscular stop (intervention of Latarjet).
Like in many domains, surgical techniques have evaluated towards the search for endoscopic alternatives to open surgery, more deleterious.
Bankart's intervention has been performed arthroscopically since the 1980s and remains the majority intervention in the United States. However, its success rate never reached that of open techniques, Bankart and Latarjet. Surgeons therefore sought the predictors of these failures in order to define the limits of the indications for arthroscopic Bankart intervention.
The determination and use of the preoperative instability score (Instability Severity Index Score : ISIS) described by Balg and Boileau is one of the ways to clarify these indications.
The aim of this study is to prospectively establish the values of the ISIS score to obtain an acceptable recurrence rate of long-term instability
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ISIS cohort
Patients operated between December 2007 and December 2008 for recurrent shoulder instability using the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of indication for surgery an ISIS score ≤ 4 points
Phone follow-up
Phone follow-up
Through a short phone interview :
* Determination of a complication (Infection, capsulitis, recurrence)
* Determination of the Rowe score
* Determination of the Walch-Duplay score
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phone follow-up
Through a short phone interview :
* Determination of a complication (Infection, capsulitis, recurrence)
* Determination of the Rowe score
* Determination of the Walch-Duplay score
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who already volunteered in a first ISIS study
* Patients operated between December 2007 and December 2008 for recurrent shoulder instability, according to the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of the indication of operation an ISIS score of ≤ 4 points (regardless of the positive criteria) (see Annex 2- ISIS score)
* Age\> 16 years
* Supported by a joint arthroscopic technique completed.
* Patient not objecting to his participation in the study
Exclusion Criteria
* Voluntary or multidirectional instability at the time of the indication of operation
* Painful shoulder without instability felt at the time of the operative indication
* Lesion of the cap (perioperative report)
* Humeral lesions Avulsion Gleno-humeral Ligament (per-operative finding)
* Unsuccessful technique
* Major benefiting from a legal protection measure (safeguard of justice, trusteeship, guardianship)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hervé THOMAZEAU, MD, PhD
Role: STUDY_DIRECTOR
Rennes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique parc Rambot Provençale
Aix-en-Provence, , France
Clinique Générale d'Annecy
Annecy, , France
Hôpital Ambroise Paré
Boulogne-Billancourt, , France
Clinique du Cambresis
Cambrai, , France
Clinique des Cèdres
Échirolles, , France
Clinique François 1er
Le Havre, , France
Clinique du Sport de Bordeaux-Mérignac
Mérignac, , France
Hôpital Archet II
Nice, , France
Hôpital Saint-Antoine / APHP
Paris, , France
Clinique Turin
Paris, , France
Centre Hospitalier Universitaire de RENNES
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01665-48
Identifier Type: OTHER
Identifier Source: secondary_id
35RC17_3025
Identifier Type: -
Identifier Source: org_study_id